262 related articles for article (PubMed ID: 33183273)
41. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study.
Prati F; Di Vito L; Biondi-Zoccai G; Occhipinti M; La Manna A; Tamburino C; Burzotta F; Trani C; Porto I; Ramazzotti V; Imola F; Manzoli A; Materia L; Cremonesi A; Albertucci M
EuroIntervention; 2012 Nov; 8(7):823-9. PubMed ID: 23034247
[TBL] [Abstract][Full Text] [Related]
42. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography.
Yonetsu T; Kato K; Uemura S; Kim BK; Jang Y; Kang SJ; Park SJ; Lee S; Kim SJ; Jia H; Vergallo R; Abtahian F; Tian J; Hu S; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Yu B; Kakuta T; Jang IK
Circ Cardiovasc Imaging; 2013 Sep; 6(5):665-73. PubMed ID: 23922003
[TBL] [Abstract][Full Text] [Related]
43. Predictors of side branch compromise in calcified bifurcation lesions treated with orbital atherectomy.
Barman N; Okamoto N; Ueda H; Chamaria S; Bhatheja S; Vengrenyuk Y; Gupta E; Sweeny J; Kapur V; Hasan C; Baber U; Moreno P; Sharma S; Kini AS
Catheter Cardiovasc Interv; 2019 Jul; 94(1):45-52. PubMed ID: 30511359
[TBL] [Abstract][Full Text] [Related]
44. Trends and outcomes of optical coherence tomography use: 877 patients single-center experience.
Paraggio L; Burzotta F; Aurigemma C; Scalise R; Leone AM; Niccoli G; Porto I; Genuardi L; Dato I; Trani C; Crea F
Cardiovasc Revasc Med; 2019 Apr; 20(4):303-310. PubMed ID: 30609972
[TBL] [Abstract][Full Text] [Related]
45. Clinical Significance of the Presence or Absence of Lipid-Rich Plaque Underneath Intact Fibrous Cap Plaque in Acute Coronary Syndrome.
Hoshino M; Yonetsu T; Usui E; Kanaji Y; Ohya H; Sumino Y; Yamaguchi M; Hada M; Hamaya R; Kanno Y; Murai T; Lee T; Kakuta T
J Am Heart Assoc; 2019 May; 8(9):e011820. PubMed ID: 31057022
[TBL] [Abstract][Full Text] [Related]
46. Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: The OCT-FORMIDABLE study registry.
Iannaccone M; Souteyrand G; Niccoli G; Mancone M; Sardella G; Tamburino C; Templin C; Gili S; Boccuzzi GG; D'Ascenzo F
Catheter Cardiovasc Interv; 2018 Dec; 92(7):E486-E492. PubMed ID: 29745476
[TBL] [Abstract][Full Text] [Related]
47. In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography.
Wang X; Matsumura M; Mintz GS; Lee T; Zhang W; Cao Y; Fujino A; Lin Y; Usui E; Kanaji Y; Murai T; Yonetsu T; Kakuta T; Maehara A
JACC Cardiovasc Imaging; 2017 Aug; 10(8):869-879. PubMed ID: 28797408
[TBL] [Abstract][Full Text] [Related]
48. Association between food and nutrients intakes and coronary plaque vulnerability in patients with coronary heart disease: An optical coherence tomography study.
Wang W; Wang Y; Gao X; Zhao Z; Li L; Yu B; Liu G; Lin P
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):201-208. PubMed ID: 33268215
[TBL] [Abstract][Full Text] [Related]
49. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome.
Lee T; Murai T; Isobe M; Kakuta T
Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685
[TBL] [Abstract][Full Text] [Related]
50. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
[TBL] [Abstract][Full Text] [Related]
51. Uncovered Culprit Plaque Ruptures in Patients With ST-Segment Elevation Myocardial Infarction Assessed by Optical Coherence Tomography and Intravascular Ultrasound With iMap.
Hougaard M; Hansen HS; Thayssen P; Antonsen L; Jensen LO
JACC Cardiovasc Imaging; 2018 Jun; 11(6):859-867. PubMed ID: 28734913
[TBL] [Abstract][Full Text] [Related]
52. Prognostic impact of healed coronary plaque in non-culprit lesions assessed by optical coherence tomography.
Usui E; Mintz GS; Lee T; Matsumura M; Zhang Y; Hada M; Yamaguchi M; Hoshino M; Kanaji Y; Sugiyama T; Murai T; Yonetsu T; Kakuta T; Maehara A
Atherosclerosis; 2020 Sep; 309():1-7. PubMed ID: 32836017
[TBL] [Abstract][Full Text] [Related]
53. Using optical coherence tomography and intravascular ultrasound imaging to quantify coronary plaque cap thickness and vulnerability: a pilot study.
Lv R; Maehara A; Matsumura M; Wang L; Wang Q; Zhang C; Guo X; Samady H; Giddens DP; Zheng J; Mintz GS; Tang D
Biomed Eng Online; 2020 Nov; 19(1):90. PubMed ID: 33256759
[TBL] [Abstract][Full Text] [Related]
54. [Intravascular ultrasound with virtual histology in assessment of atherosclerotic plaque composition in patients with coronary artery disease and type 2 diabetes mellitus].
Zakharov AS; Michurova MS; Terekhin SA; Kalashnikov VY; Smirnova OM; Shestakova MV; Dedov II
Ter Arkh; 2019 Dec; 91(12):41-46. PubMed ID: 32598588
[TBL] [Abstract][Full Text] [Related]
55. Optical Coherence Tomography-Guided Percutaneous Coronary Intervention With Low-Molecular-Weight Dextran - Effect on Renal Function.
Kurogi K; Ishii M; Sakamoto K; Komaki S; Kusaka H; Yamamoto N; Takashio S; Arima Y; Yamamoto E; Kaikita K; Tsujita K
Circ J; 2020 May; 84(6):917-925. PubMed ID: 32350234
[TBL] [Abstract][Full Text] [Related]
56. Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
Kimura S; Sugiyama T; Hishikari K; Nakagama S; Nakamura S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A
Atherosclerosis; 2020 Jan; 292():127-135. PubMed ID: 31805452
[TBL] [Abstract][Full Text] [Related]
57. Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes.
Burgmaier M; Frick M; Liberman A; Battermann S; Hellmich M; Lehmacher W; Jaskolka A; Marx N; Reith S
Cardiovasc Diabetol; 2013 Jul; 12():102. PubMed ID: 23844855
[TBL] [Abstract][Full Text] [Related]
58. Circulating annexin A5 levels are associated with carotid intima-media thickness but not coronary plaque composition.
Burgmaier M; Reith S; Schurgers L; Kahles F; Marx N; Reutelingsperger C
Diab Vasc Dis Res; 2017 Sep; 14(5):415-422. PubMed ID: 28592134
[TBL] [Abstract][Full Text] [Related]
59. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
60. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
